Professional Articles (page one)

(JWC single author unless otherwise noted) ( P-x)
Refereed=*
1. The emphasis is on clinical pharmacy. Pharm Quart 1974;6:5 8.

2. *Hexachloraphene vs. povidone iodine in the control and prophylaxis of neonatal and surgical infection. Hosp Form Mgt 1974; 9:12 14.

3.* Cooper JW, Campbell NA. Community hospital practitioner consultation: is the patient profile a viable means of future role expansion and professional unification. J Amer Pharm Assoc 1975; NS15 484 488.

4.* Fish KH, Cooper JW. The development of a non computerized system for drug drug interaction detection. J Amer Pharm Assoc 1975;NSl5:1,28 31. And 2000; 40:545.

5. The Common Cold and Cold Remedies, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, January 1975.

6. Upper and Downers, syndicated to 200 New England Newspapers via University of Rhode Island Public Information Office, February, 1975.

7.* Fish KH, Cooper JW, Schwartz PA. Teaching process skills in clinical pharmacy orientation. Am J Pharm Ed 1975;40:306 309.

8.* Implications of Drug Reactions Recognition, Incidence and Prevention, RI Med J 1975; 59:274 288.

9. Patient Profiles Why Bother?.Pharm Quart 1975; 7: 3 7.

10. Community and Hospital Pharmacist How They Cooperate to Reduce Medication Problems. Pharm Times 1975;41; 40 44.

11. Pharmacists Work Together to Improve Patient Care.Trends in Pharmacy (July August, 1975).

12.* Food Drug Interactions. US Pharm 1976; 1:17 28.

13.* Drug Related Problems and the Elderly. Sou Pharm J 1977; 69:11 15.

14.* Urinary Tract Infections I.Cause and Prevention. Hosp Form 1977;12:106 110.

15.* Urinary Tract Infections II.Optimal Therapy. Hosp Form 1977; 12:175 183.

16.* Creatinine Clearance Projection. Hosp Form 1977; 12:283.

17.* Chronic Obstructive Airway Disorders I. Asthma. Hosp Form 1977; 12:524 529.

18.* Chronic Obstructive Airway Disorders II. Chronic Bronchitis and Emphysema Hosp Form 1977;12:579 582.

19.* Cooper JW, et al.Patient Medication Profiles. Pharm J of Great Britain 1977; 52 71.

20. *Nalidixic Acid. Hosp Form 1977; 12:634 6 (Letter).

21.* Drug Therapy in the Elderly Is It All It Could Be? Amer Pharm 1978;NS18:25 26.

22.* Prophylaxis with Steroids in Asthma. Hosp Form 1978;13:654 656 (Letters).

23. Drug Related Problems and Patient Education.Ga Pharm Quart 1978; 55:1.

24.* Cooper JW, et. al. Pharmacy and the Elderly, U.S. DHWE HRA Pub. No. 232 78 0176 (February 15, 1979).

25.* The Role of Clinical Pharmacy in Pharmacy Practice.Ga Pharm 1979; 32:8 9.

26. Standards for Consultant Pharmacy. Contemp Adm 1979; 2:18 19.

27. Drug Use Review in LTCF. Pharm Pract editorial, 1979; 12:30.

28. Drug Distribution Systems in LTCF. Contemp Adm 1979; 2:21 22.

29. Clinical Functions of the Consultant Pharmacist,ibid.(7), 1979; 19 20, 30.

30. Literature of Consultant Pharmacy, ibid.(8):26 7.

31. Medication Errors in the LTCF Definition, Recognition and Prevention,ibid.(10), 27 28.

32. Drug History Acquisition, Interview, Evaluation and Communication, ibid.,3:18 19 (January, 1980).

33.* Diuretics in the Elderly Patient. Drug Ther 1979; 9:l0 (Letter).

34. Committee Functions of the Consultant Pharmacist. Contemp Adm 1980;3(2):17 18.

35. Drug Related Problems and the Geriatric Patient. Drug Store News 1980;3(4):8 16.

36. Writing A Problem List for the LTCF Patient, Contemp Adm 1981; 3(4):6 8.

37. Stop Order Policy for the LTC Facility. Contemp Adm 1980; 3(5):12.

38. Policy and Procedure Manual Development, ibid., 1981; 4(1):9.

39. Professional Publications. Ga Pharm Quart 1980; 57, (4):2.

40. Drug Regimen Review in the LTC Facility. Contemp Adm 1980; 3(7):98.

41. Formulary System in Long Term Care Facilities,ibid., 1981; 4(3):11.

42. Consultant Pharmacy Roles and Resources. Drug Store News 1981;3:2.

43. Books for Continued Clinical Education. Ga Pharm Quart 1981;58 No. 1, 2.

44. Practitioner Oriented Periodicals. Ga Pharm J 1981; 4:1.

45. Pharmacist Clinical Functions I-Drug History.Drug Store News 1981;3

46. Vitamin K Deficiency and Replacement. Ga Pharm Quart 1981 58, (2):2.

47.* Assessing Antihypertensive Therapy in the Geriatric Patient. Clinical Cons 1981; l(4).

48. Adverse Drug Reactions and Interactions in the Long Term Care Patient. Contemp Adm 1981;4(9):30, 36.

49. Medication Regimen Compliance in the LTC Patient ibid. 1981; 4(10):20.

50. High Blood Pressure in the Elderly.ibid. 1981; 4(11):8,25..

51. Diuretic Antihypertensives in the LTC Patient.ibid.1981; 4(10):20.

52. Potassium Supplementation in the LTC Patient.ibid. 1981; 4(12):40 41.

53. Sympatholytic Antihypertensives.ibid.1982;(1):30 31

54. Vasodilator Antihypertensives. ibid.1982; 5(2):18.

55. The Drug Cutbacks. Contemp Adm 1982; 5(3):32 33

56. Staff Education and Drug Use Control. Contemp Adm 1982; 5(5):8 10.

57. Nitroglycerin Oral Dosage Forms.ibid. 1982; 5(6):10 12.

58. Nitroglycerin Topical Dosage Forms. ibid. 1982; 5(7):7.

59. Beta Blocking Agents. ibid. 1982; 5(9):14.

60. The Problem List. Contemp Adm 1982; 5(12):26 28.

61. Consulting Pharmacist.ibid. 1983; 6(1):24.

62. Using the New Indicators.ibid. 1983; 6(2):4 6.

63. Drug Therapy Situations Requiring Communications.ibid. 1983; 6(3):18.

64. Drug Irregularities Documentation. ibid. 1983; 6(4): 4, 30.

65. Monitoring Drug Interactions in the Geriatric LTC Patient. Clin Consult,1983; 3: No. 2.

66. Use Digitalis with Care. Contemp Adm 1982; 5(11):34.

67. *Reactions to Post Graduate Education. Drug Intel Clin Pharm 1984; 18:330.

68. *Allopurinol Warfarin Interaction. Drug Ther 1984; 14:155. (letter)

69. Detection and Treatment of Sexually Transmitted Diseases. Drug Store News 1985.

70. Nutrient and Drug Interrelationships ibid. 4 Apr 1985.

71. Digoxin Drug Interactions. Contemp Adm 1984; 7(2):20 22.

72. Diuretic Drug Interactions. ibid. 1984; 7(3):36 38.

73. Anticonvulsant Interactions ibid. 1984;7(4):19 23.

74. Consultant Pharmacist Qualifications and Functions. Nurs Homes 1984;33(2):12 13.

75. The Need for Consultant Pharmacist Services in Long Term Care ibid.33(6):11 12.

76. Medication Errors in Nursing Homes Part I ibid. 1985;34(1):12 13.

77. Medication Errors in Nursing Homes Part II ibid. 1985(2);34:12 14.

78.* Sublingual Nitroglycerin at the Bedside. J Am Med Assoc 1984; 252:1926.

79. Antihypertensive Drug Interactions: Part I. Nurs Homes 1985; 34(3):11 12.

80. ibid. Parts II & III. 11 13.

81. Anticoagulant Drug Interactions. Part I. ibid.34(4):17 19.

82. ibid. Part II. 15 17.

83. Neuroactive Drug Interactions in the LTCF Patient: Part I- Assumptions and Questions. Nurs Homes 35:12 15 1986.

84. ibid. Part II 16 20.

85. Digitalis Drug Interactions. ibid. 1986;35 35 39.

86. Gastrointestinal Drug Interactions. ibid. 48 51.

87. Antidiabetes Drug Interactions. Ibid., 63 68.

88.* Wade WE, Cooper JW. Monitoring Therapy in the HypertensivePatient-I. US Pharm 1985; 10(6):46 53.

89. *Wade WE, Cooper JW. Monitoring the Hypertensive Patient II. Patient Information. ibid.(7):46 50.

90. Monitoring Anticonvulsant Drug Interactions and Blood Levels. Nursing Homes 1986; 35(6):11 13.

91. Monitoring Pulmonary Therapy ibid. 35(6):21 24.

92.* H 1 Blockers: Classical Antihistamines. New Engl Reg Allerg Proc 1987; 7:356 361.

93 103. Editorials. J Geriatr Drug Ther 1986-1988; 1(1):1. 2:(4):1

104.* Drug Related Problems at all levels of Geriatric Patient Care. J Geriatr Drug Ther 1990; 4(3):79 83.

105.* Drug Related Problems in Nursing Home Patients. Generat 1988; 12(4):56 7.

106.* Cost Savings: The Value of the Pharmacist Consultant. J Pharm Pract 1988;1:173 7.

107.* Consultant Pharmacist Impact on Health Care in America. Cons Pharm 1988; 3:342 6.

108 116. Editorials. J Geriatr Drug Ther 1988 90 Vol. 3 No. 1 thru Vol. 4 No.4.

117. Current Geriatric Drug Therapy Literature Citations. J Geriatr Drug Ther 1987; 2(1):79 87.

118. Current Geriatric Pharmacokinetic Literature Citations ibid., 3(1):93 9.

119. Current Geriatric Cardiovascular Literature Citations. ibid. (2):105 113.

120. Current NSAID Literature ibid. (4):151 2.

121. Current Adverse Drug Reactions ibid. (3):107 9.

122. Current Immunotherapy, Psychotropic and Renal Function Literature ibid.4(3).77 79.

123. Physician and Pharmacist Roles in Patient Compliance. Pharm Times 1990;25:9 71.

124.* The Development of Geriatric Education in the United States of America,3rd International Congress on Geriatric Pharmacotherapy Proceedings, Alicante, Spain October 1989 Geriatrica 1989;5(9):22 28, Pharmalink 1990; 3(6):9 21. and J Geriatr Drug Ther 1991; 5(4):21 38.

125. Mammy Blue. J Geriatr Drug Ther 1990; 4(3); 3 5.

126. Problems in Dealing With the Nursing Home Patient, ibid. 1990; 4(1):51 58.

127. *Special Drug Considerations in the Last Year of Life. Geriatr 1989;44(12):79 86.

128. Gramps. J Geriatr Drug Ther 1990; 4(4):5 6.

129.* Drug Abuse in Nursing Homes, used by Rep. Mario Biaggi as reference in Hearing before Select Committee on Aging, House of Representatives, 96th Congress, June 25, 1978.

130.* Management of Diabetes Mellitus Complications, Clinical Consult 1990; 9(3):1 6.131. Diabetes in the Elderly. J Geriatr Drug Ther 1990; 5(1):1 2.

132. Diabetes Citations. ibid. 85 87.

133. OBRA Regulations and Chemical Restraints. Nurs Homes 1990; 39(6):10 13.

134. Chemical Substance Impaired Health Care Professional ibid. (5); 6 7, 36.

135. Use of Chemical Restraints in Nursing Homes ibid.1989; 38 (1&2):5 7.

136. High Blood Pressure Monitoring Guidelines: Diuretics. ibid. (3):7 9.

137. Congestive Heart Failure Management Guidelines.ibid. 1990; 39(1):8 10.

138. High Blood Pressure Monitoring Guidelines: Sympatholytics and Vasodilators ibid. (2):7 9.

139 142. Editorials J Geriatr Drug Ther 1990 1991; 5(1 4).

143. *Geriatric Pharmacy Education in the United States of American ibid.; 5(4):26 38.

144. Renal Geriatric Citations, ibid. 5(3):91 3.

145.*Stroke Management. Clin Consult 1991;10(2):1 6.

146. *Peripheral Vascular Disease ibid. (3):1 6.

147. *Liver Assessment in Long Term Care Patients. ibid.(4):1 6.

148. What to Expect from your Consultant Pharmacist. Nurs Homes 1991; 40(1):37 39.

149. Pressure Sores in the Nursing Facility,ibid.(2):39 41.

150. Infection Control in Nursing Homes,ibid.(3):42 44.